Revolutionizing Alzheimer's Diagnosis

This chapter focuses on recent advancements in diagnosing Alzheimer's, particularly the new FDA-approved blood test for detecting amyloid plaques in the brain. It also discusses the implications of this test, including concerns about its misuse and the need for support for unpaid family caregivers.